1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global DNA Vaccine Market Outlook 2022

Global DNA Vaccine Market Outlook 2022

  • August 2016
  • 85 pages
  • ID: 3621489

Summary

Table of Contents

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. Various vaccines have been introduced in the market based on this technique. Some of the major DNA vaccines include GlaxoSmithKline’s Engerix-B, Twinrix, and Fendrix; Merck’s Gardasil, and Recombivax HB; Protein Sciences Corporation’s Flublok, etc. Currently, the researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are already present in the market. These vaccines are third generation vaccines, and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response.

This comprehensive report by RNCOS entitled “Global DNA Vaccine Market Outlook 2022” provides an in-depth analysis of the global DNA Vaccines market, presenting readers a profound understanding of the various challenges, drivers, and developments in this industry. The study has publicized that though the numbers of DNA vaccines that target the human clinical segment are relatively fewer in number, however due to high sales of these vaccines, the DNA vaccine market is estimated to reach US$ 7 Billion by the end of 2016.

The report also contains detailed and in-depth analysis of the segmentation of the DNA vaccines market based on types of DNA vaccines, therapeutic indication, end-users, and geography. Based on the type, the DNA vaccines market is divided into recombinant protein and genetic. In 2016, recombinant protein segment is estimated to account for largest share in the market. This large share is attributed to the presence of high number of recombinant protein vaccines in the market.

Based on end-user, the report segments the market into human and animal. The majority of DNA vaccines available in the market are targeted for humans. Moreover, the strong pipeline of human targeted vaccines is likely to aid the market growth.

Based on geography, the report further divides the market into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. North America is the largest market for DNA vaccines. The large share of the market is attributed to government’s initiatives to immunize citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. The Asia-Pacific region is slated to witness the highest growth in the forecasted period. This growth is likely to be driven by rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B.

The report also includes pipeline analysis based on the type of phase, therapeutic indications, and type of diseases for which the vaccines have been designed, such as infectious and vector borne diseases, and various types of cancers.

Major players in the DNA Vaccines market are also profiled with company overview, financial overview, product portfolios, recent developments, and strengths and weaknesses. The last section of the report discusses about the recommendations which could help the DNA vaccine market grow at a faster pace. Conclusively, the research will prove to be a useful resource for all debut makers in DNA vaccine industry, and potential investors.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast to 2022

Veterinary/Animal Vaccines Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of ...

Global Cholera Vaccines Market 2018-2022

Cholera Vaccines Sector: Worldwide Forecast until 2022

  • $ 3500
  • Industry report
  • December 2017
  • by Infiniti Research Limited

About Cholera VaccinesThe cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across ...

Global Companion Animal Specialty Drugs Market 2017-2021

Companion Animal Specialty Drugs Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • November 2017
  • by Infiniti Research Limited

About Companion Animal Specialty DrugsCompanion animals are becoming a part of urban population. The factors that have contributed to increased companion animal ownership includes nuclear families and ...


Download Unlimited Documents from Trusted Public Sources

Global Vaccine Market and Influenza Statistics

  • January 2018
    5 pages
  • Vaccine  

    Influenza  

  • United Kingdom  

    World  

View report >

HIV Antiviral Market and HIV AIDS Statistics in the US

  • December 2017
    6 pages
  • HIV Antiviral  

    Antiviral  

    HIV AIDS  

  • United States  

    France  

View report >

Vaccine Market in Guinea

  • December 2017
    10 pages
  • Vaccine  

  • Guinea  

    Africa  

View report >

Vaccine Market 1 month ago


Related Market Segments :

Vaccine

ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.